RxDoctor Payments DataLook up a doctor →

Catherine Kamau

Adult Health · Plano, TXNPI 1275777955

Payments from drug & device makers

$13,111in general payments, 2019–2025

Across 499 payments — averaging $26.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Livanova USA, Inc.$3K
  • AbbVie$2K
  • SK Life Science, Inc.$1K
  • UCB, Inc.$1K
  • Aucta Pharmaceuticals, Inc.$569
  • EMD Serono, Inc.$505
  • plus $5K from 53 others

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Livanova USA, Inc.21$3,070
AbbVie(2 entities)111$1,754
SK Life Science, Inc.35$1,202
UCB, Inc.58$1,089
Aucta Pharmaceuticals, Inc.25$569
EMD Serono, Inc.10$505
Amgen22$491
Teva Pharmaceuticals USA, Inc.20$395
Biogen15$357
Neurelis, Inc.8$271
Lilly USA, LLC16$255
Jazz Pharmaceuticals Inc.7$200
Genentech USA, Inc.7$174
Pfizer9$174
Alnylam Pharmaceuticals Inc.7$148
Bristol Myers Squibb7$146
Medtronic5$140
Otsuka America Pharmaceutical, Inc.7$133
Eisai Inc.5$131
Biohaven Pharmaceutical Holding Company Ltd.10$124
Avanir Pharmaceuticals, Inc.14$116
Merz Pharmaceuticals, LLC3$98
Neurocrine Biosciences, Inc.4$98
Lundbeck LLC5$95
Ipsen Biopharmaceuticals, Inc5$95
Sunovion Pharmaceuticals Inc.4$78
Springworks Therapeutics, Inc.3$76
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC3$62
Sanofi3$62
Aprecia Pharmaceuticals, LLC3$60
Novartis3$59
Averitas Pharma Inc.2$57
Arbor Pharmaceuticals, Inc.4$57
Axsome Therapeutics, Inc.2$56
Scilex Pharmaceuticals Inc.3$56
Acadia Pharmaceuticals Inc3$54
Takeda Pharmaceuticals U.S.A., Inc.2$49
Upsher-smith Laboratories LLC2$41
Biotronik NRO, Inc.1$39
Boston Scientific1$38
Life Molecular Imaging Ltd2$38
Octapharma USA, Inc.2$37
Impel Pharmaceuticals Inc.2$37
Otter Pharmaceuticals, LLC1$36
Currax Pharmaceuticals LLC2$25
Kyowa Kirin, Inc.1$24
Supernus Pharmaceuticals, Inc.1$23
AstraZeneca1$23
GRT US Holding, Inc.2$22
Tonix Medicines, Inc.1$22
TG Therapeutics, Inc.1$20
GE HealthCare1$19
Johnson & Johnson1$17
Vanda Pharmaceuticals Inc.1$17
E.r. Squibb & Sons, L.L.C.1$17
Almatica Pharma LLC1$16
Grifols USA, LLC1$16
Metacel Pharmaceuticals LLC1$15
Azurity Pharmaceuticals, Inc.1$13

How this compares

$13,111 in reported general payments places this provider in the 95th percentile of 933 adult health providers in Texas.

See all adult health providers in Texas →

Medicare billing

Part B allowed, 2024
$2,530
Medicare patients
29
Services billed
30

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other adult health in Plano

See the full list for Texas →

Where these figures come from

Is this you, or does something look wrong? →